Join to view full profile
1450 Chapel St# SasintNew Haven, CT 06511
Phone+1 203-789-4044
Fax+1 203-789-3007
Dr. Tarabar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Occupational and Environmental Medicine, 2001 - 2003- Yale-New Haven Medical CenterResidency, Internal Medicine, 1998 - 2001
OtherClass of 1994
Certifications & Licensure
CT State Medical License 2003 - 2020
Publications & Presentations
PubMed
- 41 citationsOral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase...Christopher Tehlirian, Ravi Shankar P Singh, Vivek Pradhan, Erika S Roberts, Sanela Tarabar
Journal of the American Academy of Dermatology. 2022-08-01 - 15 citationsSafety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.Srividya Neelakantan, Barry Oemar, Kristen Johnson, Natalie Rath, Mikhail Salganik
Clinical Pharmacology in Drug Development. 2021-03-01 - 51 citationsSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study.Arthur Bergman, Santos Carvajal-Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler
Clinical Pharmacology in Drug Development. 2020-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
